SCHEMBL4958017

SCHEMBL4958017

CCCCC(=O)Nc1c(C)csc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.49
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 1/20 0.49
HPGD P15428 1/20 0.49
CYP1A2 P05177 3/20 0.47
CYP2C19 P33261 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4957059 0.86 CYP1A2 (0.61) POLBALDH1A1KMT2AHPGDCYP1A2
SCHEMBL23295963 0.80 ALDH1A1 (0.52) POLBALDH1A1KMT2ACYP1A2CYP2C19
SCHEMBL28229016 0.78 ALDH1A1 (0.44) POLBALDH1A1KMT2ACYP1A2CYP2C19
Hydrochloric Acid SCHEMBL31538653 0.75 ALDH1A1 (0.48) POLBALDH1A1KMT2ACYP1A2CYP2C19
SCHEMBL7028014 0.75 CYP1A2 (0.47) POLBALDH1A1KMT2ACYP1A2CYP2C19
SCHEMBL14263853 0.74 HDAC3 (0.73) POLBALDH1A1KMT2AHPGDCYP1A2
SCHEMBL6317855 0.74 ALDH1A1 (0.56) POLBALDH1A1KMT2ACYP1A2CYP2C19
Hydrochloric Acid SCHEMBL7035051 0.74 CYP1A2 (0.46) POLBALDH1A1KMT2ACYP1A2CYP2C19
SCHEMBL4565884 0.73 HDAC3 (0.57) POLBALDH1A1KMT2AHPGDCYP1A2
SCHEMBL31531432 0.72 KMT2A (0.59) POLBALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed